Physician profile
Stephen M Eckel
NPI 1437585163
$4,147.58
in general payments reported to CMS, 2019-2025
17 companies · $426 in 2025
The $426 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $304 · 2020: $52.74 · 2021: $1,828 · 2022: $511 · 2023: $698 · 2024: $327 · 2025: $426.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,451.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,451.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eyevance Pharmaceuticals LLC | $1,620.03 | 2021 | |
| Johnson & Johnson Vision Care, INC. | $934.86 | 2019-2025 | Acuvue |
| Alcon Vision LLC | $275.62 | 2019-2025 | Total30, Precision7 |
| Novartis Pharmaceuticals Corporation | $273.78 | 2021-2023 | |
| Carl Zeiss Meditec USA, INC. | $257.13 | 2023 | Cirrus Hd-Oct, Clarus |
| Sun Pharmaceutical Industries INC. | $148.52 | 2022-2025 | Cequa, Xelpros |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $127.26 | 2019-2021 | |
| Shire North American Group INC | $119.98 | 2019 | |
| Coopervision INC. | $88.31 | 2021-2025 | Clariti Contact Lens |
| Apellis Pharmaceuticals, INC. | $66.04 | 2025 | Syfovre |
| Bausch & Lomb Americas INC. | $58.73 | 2022-2025 | Infuse |
| Oyster Point Pharma, INC. | $44.51 | 2022-2023 | Tyrvaya |
| Allergan, INC. | $36.89 | 2019-2021 | |
| Tarsus Pharmaceuticals, INC. | $33.97 | 2024-2025 | Xdemvy |
| Horizon Therapeutics Plc | $21.64 | 2023 | Tepezza |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $20.95 | 2022 | |
| Johnson & Johnson Surgical Vision, INC. | $19.36 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Eckel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.